SummaryRMgm-5517
|
||||||||
*RMgm-5517| Successful modification | The parasite was generated by the genetic modification |
| The mutant contains the following genetic modification(s) | Gene mutation |
| Reference (PubMed-PMID number) |
Reference 1 (PMID number) : 38049852 |
| MR4 number | |
| top of page | |
| Parent parasite used to introduce the genetic modification | |
| Rodent Malaria Parasite | P. yoelii |
| Parent strain/line | P. y. yoelii 17X |
| Name parent line/clone | Not applicable |
| Other information parent line | |
| top of page | |
| The mutant parasite was generated by | |
| Name PI/Researcher | Zhong M, Zhou B |
| Name Group/Department | Faculty of Synthetic Biology |
| Name Institute | Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences |
| City | Shenzhen |
| Country | China |
| top of page | |
| Name of the mutant parasite | |
| RMgm number | RMgm-5517 |
| Principal name | Pydmt1-C2 clone and Pydmt1-A1 clone |
| Alternative name | |
| Standardized name | |
| Is the mutant parasite cloned after genetic modification | Yes |
| top of page | |
| Phenotype | |
| Asexual blood stage | A significantly reduction of parasitemia in mice infected with the mutant; 3 days after infection the parasitemia for Pydmt1-C2 clone and Pydmt1-A1 clone was each reduced by 50 and 60%, respectively. |
| Gametocyte/Gamete | Not tested |
| Fertilization and ookinete | Not tested |
| Oocyst | Not tested |
| Sporozoite | Not tested |
| Liver stage | Not tested |
| Additional remarks phenotype | Mutant/mutation Additional information: By analysis of a mutant expressing a C-terminal HA tagged version of DMT1 (RMgm-5516) the following was shown: Confocal analysis after immunostaining with HA antibody showed that PyDMT-HA surrounded the hemozoin in the blood stage, implying that PyDMT1 is likely localized on the membrane of the food vacuole. To test whether PyDMT1 acts as an iron importer in P. yoelii, a mutant was generated with a partial loss of function allele of PyDMT1 by a single crossover to the regulatory region of Pydmt1. This mutation caused a partial loss of PyDMT1 expression but resulted in severe defects, rescued by iron supplementation. From the paper: 'To test the hypothesis that the slow growth of the hypomorphic PyDMT1 parasite was due to iron deficiency caused by lower iron uptake, we counted the merozoites of the mutant Pydmt1 parasite and the parent strain without or with exogenous iron in vitro by adding Fe2+. After 18 h incubation, the number of merozoites for Pydmt1 mutant parasites (clone A1 and clone C2) was about 9, in comparison to 14 for the parent strain, consistent with the slower in vivo growth of the mutant. Meanwhile, addition of Fe2+ did not significantly increase the number of merozoites for the parent strain, indicating that iron was not a limiting factor for the normal parasite under our experimental condition. In contrast, iron supplements significantly increased the number of merozoites for the Pydmt1 mutant parasite, to a comparable level with that in the control parasite. The data indicate that it is primarily iron deficiency and not anything else that underlies the growth defects from reduced PyDMT1 expression. Next, we compared the labile iron pool (LIP) in the control parasite and clone A1. To that end, we used a similar strategy adopted by other groups; iRBCs containing both the parent parasite and clone A1 were stained with the iron- sensitive fluorescent probe Calcein-AM, and the signals were analyzed by flow cytometry. The LIP of the Pydmt1 mutant parasite iRBC was significantly lower than that of the control parasite iRBC. Noteworthy is that Fe2+ quenches the fluorescence so that higher Fe2+ levels result in lower signals. In order to make sure that these signal changes were primarily from the parasites instead of the RBC, a confocal image was further taken. The primary signal of the Calcein-AM stain indeed appeared from the parasites. Furthermore, the diffuse and stronger signal across the whole parasite suggests a reduced LIP of Pydmt1-A1 in the cytosol. We then determined whether the number of merozoites in Pydmt1 mutant parasite could be reverted by other metals. Given the same nature of the different Pydmt1 hypomorph mutants, essentially identical results obtained with A1 and C2, and the laborious amount of work involved, we chose A1 for this work. Zinc addition partially restored the number of merozoites of clone A1, meaning that zinc supplement could, to some extent, rescue the growth defect of Pydmt1 mutant parasites. However, adding copper or manganese ions did not affect the merozoite maturation. Taken together, we conclude that the primary physiological function of PyDMT1 is iron uptake, and decreased PyDMT1 expression causes parasite iron deficiency, leading to severe physiological consequences. The perfect rescue of the PyDMT1 hypomorphs with iron, together with the observation of the inability of iron addition to enhance the growth of the wild-type pathogen, confirms our suspicion that the normal pathogen may obtain just enough iron for its optimal growth. |
Mutated: Mutant parasite with a mutated gene| top of page | |||||||||||||||||||||||||||
| Details of the target gene | |||||||||||||||||||||||||||
| Gene Model of Rodent Parasite | PY17X_1241800 | ||||||||||||||||||||||||||
| Gene Model P. falciparum ortholog | PF3D7_0523800 | ||||||||||||||||||||||||||
| Gene product | food vacuole resident transporter 1 | ||||||||||||||||||||||||||
| Gene product: Alternative name | FVRT1, PyDMT1 (Divalent metal transporter 1) | ||||||||||||||||||||||||||
| top of page | |||||||||||||||||||||||||||
| Details of the genetic modification | |||||||||||||||||||||||||||
| Short description of the mutation | The 5' UTR of the dmt1 gene is truncated. | ||||||||||||||||||||||||||
| Inducable system used | No | ||||||||||||||||||||||||||
| Short description of the conditional mutagenesis | Not available | ||||||||||||||||||||||||||
| Additional remarks inducable system | |||||||||||||||||||||||||||
| Type of plasmid/construct | CRISPR/Cas9 construct: integration through double strand break repair | ||||||||||||||||||||||||||
| PlasmoGEM (Sanger) construct/vector used | No | ||||||||||||||||||||||||||
| Modified PlasmoGEM construct/vector used | No | ||||||||||||||||||||||||||
| Plasmid/construct map | |||||||||||||||||||||||||||
| Plasmid/construct sequence | |||||||||||||||||||||||||||
| Restriction sites to linearize plasmid | |||||||||||||||||||||||||||
| Selectable marker used to select the mutant parasite | hdhfr | ||||||||||||||||||||||||||
| Promoter of the selectable marker | eef1a | ||||||||||||||||||||||||||
| Selection (positive) procedure | pyrimethamine | ||||||||||||||||||||||||||
| Selection (negative) procedure | No | ||||||||||||||||||||||||||
| Additional remarks genetic modification | To analyse the function of DMT1, a partial loss of function mutant (hypomorph) was generated. Truncating the regulatory region by inserting a selectable cassette into the upstream of a gene could reduce its expression. We decided to insert an hdhfr(coding for the human dihydrofolate reductase) selectable cassette at the Pydmt1 locus upstream of the coding region of Pydmt1-HA to knock down its expression. In the Plasmodium database, we found that Pydmt1 shares the same regulatory region of approximately 4.1 kb with an adjacent gene, PY17X_1241700, whose function remains unknown. To minimize the undesirable effect on this neighbor gene, we designed a single insertion strategy to shorten the regulatory region of Pydmt1 without altering the entire 4.1 kb regulatory region of PY17X_1241700. Multiple attempts to put the cassette in at − 400, − 600, − 800, − 1200, and − 1600 bp upstream of Pydmt1 were unsuccessful. However, a recombinant clone was obtained by inserting the hdhfr cassette at the − 2000 bp position. After limiting dilution and mice infection, we obtained six independent clones, among which two clones (Pydmt1-A1 and Pydmt1-C2; PyDMT hypomorph) PyDMT1 hypomorph) were selected for Pydmt1 expression analysis. Inserting hdhfr at the − 2000 bp led to a reduction of Pydmt1 expression in the clones, demonstrated at both the mRNA and protein levels. This insertion, however, had little influence on the mRNA expression of the flanking gene PY17X_1241700. This roughly halving of PyDMT1 expression led to a significantly reduction of parasitemia; 3 days after infection the parasitemia for Pydmt1-C2 clone and Pydmt1-A1clone was each reduced by 50 and 60%, respectively | ||||||||||||||||||||||||||
| Additional remarks selection procedure | |||||||||||||||||||||||||||
| |||||||||||||||||||||||||||
| top of page | |||||||||||||||||||||||||||